FindTrial
Sign In

Effect of tamoxifen on clinical outcome of patients with thin endometrium undergoing frozen-thawed embryo transfer

Effect of tamoxifen on clinical outcome of patients with thin endometrium undergoing frozen-thawed embryo transfer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16007965
Enrollment
Unknown
Registered
2016-02-22
Start date
2016-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thin endometrium

Interventions

treatment group:tamoxifen
control group:letrozole

Sponsors

Nanjing General Hospital of Nanjing Military Command
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged yanger than 40 years; 2. The transferred embryo included at least one high quality embryo; 3. The endometrial thickness in nature or HRT cycle before was < 7 mm.

Exclusion criteria

Exclusion criteria: 1. donor oocyte Cycles; 2. The premature ovarian failure patients cumulatived embryos; 3. The usage of estroge before embryo transfer

Design outcomes

Primary

MeasureTime frame
the thickness of endometrium;—

Countries

China

Contacts

Public ContactLI CHEN
872276095@qq.com+86 13851828017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026